Search
Patexia Research
Case number 1:19-cv-00190

Genentech, Inc. et al v. Amneal Pharmaceuticals LLC et al > Documents

Date Field Doc. No.Description (Pages)
Jun 23, 2021 21 Order (2)
Jun 23, 2021 21 Patent/Trademark Report to Commissioner (2)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1; 7,767,700 B2; 7,816,383 B1; 7,910,610 B1; 8,031,002 B2; 8,084,475 B2; 8,318,780 B2; 8,383,150 B2; 8,420,674 B2; 8,592,462 B2; 8,609,701 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # (1) Order)(nms)
Jun 23, 2021 N/A Terminated Case (0)
Docket Text: CASE CLOSED per entry of D.I. 290 in Lead Civil Action 19-78-RGA. (nms)
Oct 5, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The notice filed at D.I. 21 has been removed from the docket. All filing are to be made in Lead Civil Action 19-78-RGA only (see D.I. [19]). (nms)
Sep 16, 2019 20 Transcript (41)
Docket Text: Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/7/2019. Redacted Transcript Deadline set for 10/17/2019. Release of Transcript Restriction set for 12/16/2019. (Triozzi, Heather)
Sep 3, 2019 19 Scheduling Order (16)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
Sep 3, 2019 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak)
Aug 30, 2019 18 Cover Letter (1)
Aug 30, 2019 18 Proposed Order (19)
Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms).
Aug 20, 2019 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb)
Aug 16, 2019 17 Letter to The Honorable Richard G. Andrews (2)
Aug 16, 2019 17 Proposed Order (26)
Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms).
Jul 26, 2019 16 Notice (Other) (4)
Docket Text: NOTICE of Name Change for Certain Pro Hac Vice Counsel by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC (Vrana, Robert)
May 16, 2019 N/A Oral Order (0)
Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
Apr 16, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Jake M. Holdreith and Kelsey J. Thorkelson for Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, and Amneal Pharmaceuticals of New York LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
Apr 15, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Oren D. Langer for Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, and Amneal Pharmaceuticals of New York LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00190-RGA, 1:19-cv-00195-RGA(ceg)
Apr 12, 2019 14 Answer to Counterclaim (30)
Docket Text: ANSWER to [11] Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 4/12/2019 (nms).
Apr 8, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith, Attorney Kelsey J. Thorkelson and Attorney Oren D. Langer, filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals of New York LLC. Signed by Judge Richard G. Andrews on 4/8/2019. (nms)
Apr 8, 2019 13 Motion for Leave to Appear Pro Hac Vice (7)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith, Attorney Kelsey J. Thorkelson and Attorney Oren D. Langer - filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Vrana, Robert)
Mar 22, 2019 12 Disclosure Statement (4)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holdings, GmbH for Amneal Pharmaceuticals Company GmbH; Corporate Parent Amneal Pharmaceuticals LLC for Amneal Pharmaceuticals of New York LLC; Corporate Parent Amneal Pharmaceuticals, Inc., Corporate Parent APHC Holdings, LLC for Amneal Pharmaceuticals LLC filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Gaza, Anne)
Mar 22, 2019 11 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against Genentech, Inc., InterMune, Inc., by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH.(Gaza, Anne) Modified on 3/25/2019 (nms).
Mar 8, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp)
Feb 19, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (10 in 19-cv-195-RGA, 10 in 19-cv-190-RGA) STIPULATION TO EXTEND TIME for Defendants to move against, answer or otherwise plead in response to the Complaint to March 22, 2019. Signed by Judge Richard G. Andrews on 2/19/2019. Associated Cases: 1:19-cv-00190-RGA, 1:19-cv-00195-RGA(nms)
Feb 18, 2019 10 Stipulation to EXTEND Time (2)
Docket Text: Joint STIPULATION TO EXTEND TIME for Defendants to move against, answer or otherwise plead in response to Plaintiffs' Complaint to March 22, 2019 - filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Vrana, Robert)
Feb 12, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
Feb 11, 2019 9 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Amneal Pharmaceuticals Company GmbH served on 2/8/2019, answer due 3/1/2019. (Blumenfeld, Jack)
Feb 11, 2019 8 Motion for Leave to Appear Pro Hac Vice (15)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen)
Feb 6, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00177-RGA, 1:19-cv-00178-RGA, 1:19-cv-00190-RGA, 1:19-cv-00195-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA, 1:19-cv-00205-RGA, 1:19-cv-00219-RGA, 1:19-cv-00223-RGA (rjb)
Feb 1, 2019 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The pdfs for the filings at D.I. [6] and [7] have been replaced with corrected versions. (ddp) Modified on 2/6/2019 (nms).
Jan 31, 2019 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Amneal Pharmaceuticals of New York LLC served on 1/31/2019, answer due 2/21/2019. (Blumenfeld, Jack) (Main Document 7 replaced on 2/1/2019) (ddp). Modified on 2/1/2019 (ddp).
Jan 31, 2019 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Amneal Pharmaceuticals LLC served on 1/31/2019, answer due 2/21/2019. (Blumenfeld, Jack) (Main Document 6 replaced on 2/1/2019) (ddp). Modified on 2/1/2019 (ddp).
Jan 30, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Amneal Pharmaceuticals Company GmbH on 1/30/2019; Amneal Pharmaceuticals LLC on 1/30/2019; Amneal Pharmaceuticals of New York LLC on 1/30/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)
Jan 30, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Genentech, Inc. for InterMune, Inc.; Other Affiliate Roche Holding Ltd., Other Affiliate Novartis Ltd., Other Affiliate Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc.. (nmg)
Jan 30, 2019 4 Patent/Trademark Report to Commissioner (2)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) SEE ATTACHED. (nmg)
Jan 30, 2019 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/22/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/15/2022. (nmg)
Jan 30, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Jan 30, 2019 1 Civil Cover Sheet (2)
Jan 30, 2019 1 Exhibit 1-15 (217)
Jan 30, 2019 1 Complaint* (1)
Menu